Menu
Recruiting NCT00896935

Arizona Cancer Center Biospecimen Repository

Observational Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: biologic sample preservation procedure.
Who it may be relevant to
Registry conditions: Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.

Detailed description

OBJECTIVES:

* Provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer. * Collect and preserve tissue from the primary organ site (uninvolved and involved with cancer), from the metastases, from patient blood (serum and lymphocytes), and from patient urine. * Provide quality-controlled storage and management of the specimen bank. * Collect relevant clinical and pathologic information with appropriate privacy protection. * Contribute to the development of a comprehensive database annotated with relevant clinical data, pathology, and research findings.

OUTLINE: This is a multicenter study.

Tumor samples, lymph node samples, and normal pancreas tissue samples are collected. Blood samples are also collected prior to surgery, six months after the initial blood draw and tissue sample collection, and every six months thereafter for two years.

Interventions

  • Other biologic sample preservation procedure
    biologic sample preservation procedure

Primary outcome measures

  • Provision of tissue samples and biospecimens for translational study [Time frame: July 2024]

Eligibility criteria

DISEASE CHARACTERISTICS:

  • Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer

PATIENT CHARACTERISTICS:

  • NA

PRIOR CONCURRENT THERAPY:

  • NA

As this is a biospecimen repository, participation is open to all cancer patients being treated at the Arizona Cancer Center or University Medical Center by investigators on this protocol.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

United States · 1 center
  • Arizona Cancer Center at University of Arizona Health Sciences Center — Tucson

Identifiers

NCT: NCT00896935 · CDR0000597579 · P30CA023074 · UARIZ-06-0609-04 · UARIZ-BIO#A06035 · UARIZ-SRC18042

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗